Cuál es el precio por Medigene AG (MDG1)

Precio por Medigene AG (MDG1) es de$0.14942078

Cuál es la capitalización de mercado por Medigene AG (MDG1)

Capitalización de mercado por Medigene AG (MDG1) es $3.86M

Medigene AG (MDG1) Desdoblamientos de Acciones

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
2024-08-29	1:2	x0.5	x0.125
2013-09-03	1:4	x0.25	x0.25

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

2024-08-29

1:2

x0.5

x0.125

2013-09-03

1:4

x0.25

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País